End-of-day quote
Shanghai S.E.
23:00:00 08/05/2024 BST
|
5-day change
|
1st Jan Change
|
19.1
CNY
|
+10.02%
|
|
+14.37%
|
+4.71%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,353
|
6,459
|
6,356
|
3,762
|
3,939
|
-
|
-
|
Enterprise Value (EV)
1 |
3,353
|
6,459
|
6,356
|
3,762
|
3,939
|
3,939
|
3,939
|
P/E ratio
|
21.2
x
|
17.9
x
|
10.9
x
|
15.1
x
|
15.4
x
|
12.5
x
|
9.7
x
|
Yield
|
-
|
-
|
1.6%
|
-
|
2.09%
|
2.62%
|
3.14%
|
Capitalization / Revenue
|
-
|
-
|
2.37
x
|
1.72
x
|
1.66
x
|
1.43
x
|
1.07
x
|
EV / Revenue
|
-
|
-
|
2.37
x
|
1.72
x
|
1.66
x
|
1.43
x
|
1.07
x
|
EV / EBITDA
|
-
|
-
|
11.3
x
|
-
|
9.82
x
|
7.77
x
|
6.24
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
2.16
x
|
-
|
1.2
x
|
1.12
x
|
1.04
x
|
Nbr of stocks (in thousands)
|
203,930
|
203,930
|
203,930
|
206,259
|
206,252
|
-
|
-
|
Reference price
2 |
16.44
|
31.68
|
31.17
|
18.24
|
19.10
|
19.10
|
19.10
|
Announcement Date
|
15/04/21
|
17/03/22
|
17/04/23
|
16/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
2,683
|
2,181
|
2,371
|
2,750
|
3,672
|
EBITDA
1 |
-
|
-
|
562.7
|
-
|
401
|
507
|
631
|
EBIT
1 |
-
|
-
|
539.1
|
300.8
|
303
|
375
|
483
|
Operating Margin
|
-
|
-
|
20.09%
|
13.79%
|
12.78%
|
13.64%
|
13.15%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
536.6
|
300.7
|
303
|
375
|
483
|
Net income
1 |
157.8
|
360.1
|
469.3
|
249.7
|
258
|
319
|
411
|
Net margin
|
-
|
-
|
17.49%
|
11.45%
|
10.88%
|
11.6%
|
11.19%
|
EPS
2 |
0.7750
|
1.769
|
2.860
|
1.210
|
1.240
|
1.530
|
1.970
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
0.5000
|
-
|
0.4000
|
0.5000
|
0.6000
|
Announcement Date
|
15/04/21
|
17/03/22
|
17/04/23
|
16/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
15.6%
|
-
|
7.7%
|
9%
|
10.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
13.2%
|
-
|
6.6%
|
7.6%
|
9%
|
Assets
1 |
-
|
-
|
3,550
|
-
|
3,909
|
4,197
|
4,567
|
Book Value Per Share
2 |
-
|
-
|
14.40
|
-
|
16.00
|
17.00
|
18.40
|
Cash Flow per Share
2 |
-
|
-
|
2.250
|
-
|
1.680
|
1.560
|
1.470
|
Capex
1 |
-
|
-
|
90.8
|
-
|
555
|
555
|
55
|
Capex / Sales
|
-
|
-
|
3.38%
|
-
|
23.4%
|
20.18%
|
1.5%
|
Announcement Date
|
15/04/21
|
17/03/22
|
17/04/23
|
16/04/24
|
-
|
-
|
-
|
Last Close Price
19.1
CNY Average target price
19.84
CNY Spread / Average Target +3.87% Consensus |
1st Jan change
|
Capi.
|
---|
| +4.71% | 546M | | +17.76% | 66.7B | | +0.84% | 48.83B | | +17.11% | 41.51B | | +18.54% | 26.72B | | +11.45% | 19.58B | | +3.89% | 18.01B | | -21.31% | 16.02B | | +3.82% | 15.58B | | -7.57% | 15.7B |
Other Specialty Chemicals
|